Healthy Extracts (HYEX) Profit After Tax Growth (3y) (2018 - 2026)
Healthy Extracts (HYEX) Profit After Tax Growth (3y) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.05 Bn | 43.08 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.39 Bn | 39.74 Bn | 2.15 Bn | 14.01% |
| 3 | Zoetis | 31.86 Bn | 30.18 Bn | 1.05 Bn | -0.23% |
| 4 | Takeda Pharmaceutical | 28.78 Bn | 22.99 Bn | 5.10 Bn | 2.89% |
| 5 | United Therapeutics | 22.25 Bn | 19.59 Bn | 683.80 Mn | 8.71% |
| 6 | Viatris | 18.74 Bn | 17.85 Bn | 1.46 Bn | -34.81% |
| 7 | Neurocrine Biosciences | 15.58 Bn | 15.19 Bn | 935.80 Mn | 15.37% |
| 8 | Elanco Animal Health | 11.92 Bn | 11.39 Bn | 798.00 Mn | 36.74% |
| 9 | Dr Reddys Laboratories | 10.16 Bn | 9.99 Bn | - | - |
| 10 | Healthy Extracts | 19.90 Mn | 19.71 Mn | 1.45 Mn | 53.26% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 53.26% |
| Dec 31, 2025 | -77.02% |
| Sep 30, 2025 | -32.44% |
| Jun 30, 2025 | 27.61% |
| Mar 31, 2025 | -412.32% |
| Dec 31, 2024 | -41.49% |
| Sep 30, 2024 | 28.87% |
| Jun 30, 2024 | 30.13% |
| Mar 31, 2024 | 12.68% |
| Dec 31, 2023 | 38.52% |
| Sep 30, 2023 | -28.80% |
| Jun 30, 2023 | 27.93% |
| Mar 31, 2023 | 44.49% |
| Dec 31, 2022 | 46.53% |
| Sep 30, 2022 | 35.81% |
| Jun 30, 2022 | -45.60% |
| Mar 31, 2022 | -87.63% |
| Dec 31, 2021 | 31.14% |
| Sep 30, 2021 | -49.39% |
| Jun 30, 2021 | -11.75% |